Friday, February 13, 2015

骨髄移植では均一な細胞集団にすることが良いわけではない

肝細胞でも同じか。

移植後に増える細胞
造血幹細胞
肝細胞
表皮細胞
上記以外にあるのかね。



抗体

腫瘍マーカー
CEA
CA125
CA19-9
c-kit
上皮系
EMA
keratin
CKAE1/AE3
CK7
a-SMA
筋系
Desmin
Myoglobin
HHF35
間葉系
Vimentin
神経系
GFAP
NSE
S-100
血管、リンパ管系
CD31
CD34
白血球系
LCA
CyclinD1
内分泌系
HGM-45M1
MUC-5AC
Insulin
Glucagon
Somatostatin
hCG
E-cadherin
肝ALB
AFP
HepPer1
増殖細胞、細胞周期
ki-67
PCNA
未分化マーカー
Oct3/4
その他
CDX2



加工

Processing
培養加工
Cell processing facility
細胞加工施設



Manipulate



pic/s

http://www.jpma.or.jp/information/quality/pdf/100915_1.pdf

pic/sについての概要が上記サイトに記載されている。



Sunday, February 8, 2015

奇形腫の成熟,未熟と良性,悪性の関係 ---専門家よりのご教授---

奇形腫の成熟,未熟と良性,悪性の関係,teratoma with malignant transformationの組織発生に関して、専門家よりご教授頂きました。

ヒトの奇形腫では,性別と年齢で状況が全く異なります.すなわち,女性の卵巣の未熟奇形腫は悪
性,成熟奇形腫は良性ですが,男性の精巣の場合は,小児の奇形腫は成熟,未熟にか
かわらず良性,成人の奇形腫は成熟,未熟にかかわらず悪性,というのが一般的な理
解だと思います.この論文の書き方は異なるように思われます.また,teratoma
with malignant transformationは卵巣の成熟奇形腫から出る扁平上皮癌がよくしら
れているものですが,これは奇形腫の未熟性とは無関係なものです.



Scripps Research Institute has won a $1.8M grant from CIRM

http://www.scripps.edu/news/press/2015/20150129loring.html



Friday, February 6, 2015

Mesenchymal Stem Cells from Bone Marrow Enhance Neovascularization and Stromal Cell Proliferation

Mesenchymal Stem Cells from Bone Marrow Enhance Neovascularization and Stromal Cell Proliferation in Rat Ischemic Limb in the Early Phase after Implantation.

Sayaka USUI, Yoshitaka ISO, Masahiro SASAI, Takuya MIZUKAMI, Chisato SATO, Masaaki KURATA, Akihiro UMEZAWA, Seiji SHIODA, Hiroshi SUZUKI

In the present study we investigated the efficacy of MSC implantation into a hindlimb ischemia model over a short-term period to elucidate the effects conferred within the early phase after treatment. MSCs from rats expressing green fluorescence protein (GFP) were injected into rat ischemic limbs. Laser Doppler perfusion imaging revealed significantly higher blood perfusion recovery in the MSC group than in the control group on days 3 and 7 after the treatment. The capillary/muscle fiber ratio in ischemic muscle was also significantly higher in the MSC group than in the controls in a histological study. In spite of these benefits, we found no evident engraftment of the GFP-positive cells, and instead, the MSC treatment induced a proliferation of resident stromal cells in the perivascular area of the ischemic muscle, some of which produced vascular endothelial growth factor. The present study suggested that MSC therapy promotes neovascularization even in the early phase, both directly through endothelial proliferation and indirectly through activation of the resident stromal cells.

https://www.jstage.jst.go.jp/article/sujms/26/2/26_121/_pdf